Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.25
-0.02 (-0.02%)
At close: Aug 15, 2025, 1:51 PM
VRNA Gamma Exposure By Expiry
The total Gamma Exposure (GEX) for VRNA across all expirations is 30,663.7 shares per 1% move, with 44,669.19 from calls and 14,005.49 from puts. The put-call GEX ratio of 0.31 shows call-heavy positioning, potentially creating volatility as market makers hedge by selling into strength and buying weakness. The highest gamma concentration is at the Jan 16, 26 expiration with 23,776.07 net GEX, which may act as a magnet point for price action. Near-term exposure for Sep 19, 25 suggests potential support from positive gamma hedging flows.
VRNA GEX Table
| Expiry Date | Call GEX | Put GEX | Net GEX | P/C GEX |
|---|---|---|---|---|
| Sep 19, 25 | 6,039.96 | -4,372.14 | 1,667.82 | 0.72 |
| Oct 17, 25 | 33.21 | -10.26 | 22.95 | 0.31 |
| Nov 21, 25 | 300.5 | -1.75 | 298.75 | 0.01 |
| Dec 19, 25 | 10,768.51 | -6,287.8 | 4,480.71 | 0.58 |
| Jan 16, 26 | 26,522.35 | -2,746.28 | 23,776.07 | 0.10 |
| Mar 20, 26 | 10.42 | -2.94 | 7.48 | 0.28 |
| Jan 15, 27 | 994.24 | -584.32 | 409.92 | 0.59 |